Gamma-delta (γδ) T cells: friend or foe in cancer development? Y Zhao, C Niu, J Cui Journal of translational medicine 16, 1-13, 2018 | 309 | 2018 |
FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer L Li, W Li, N Chen, H Zhao, G Xu, Y Zhao, X Pan, X Zhang, L Zhou, D Yu, ... Clinical Cancer Research 25 (4), 1302-1317, 2019 | 126 | 2019 |
Nuclear-encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in HCC cells through the mitophagy pathway Y Zhao, L Zhou, H Li, T Sun, X Wen, X Li, Y Meng, Y Li, M Liu, S Liu, ... Molecular Therapy-Nucleic Acids 23, 264-276, 2021 | 74 | 2021 |
The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena Y Zhao, L Sun, RR Wang, JF Hu, J Cui Critical reviews in oncology/hematology 131, 76-82, 2018 | 62 | 2018 |
Prognostic value of MICA/B in cancers: a systematic review and meta-analysis Y Zhao, N Chen, Y Yu, L Zhou, C Niu, Y Liu, H Tian, Z Lv, F Han, J Cui Oncotarget 8 (56), 96384, 2017 | 59 | 2017 |
Aberrant shuttling of long noncoding RNAs during the mitochondria-nuclear crosstalk in hepatocellular carcinoma cells Y Zhao, S Liu, L Zhou, X Li, Y Meng, Y Li, L Li, B Jiao, L Bai, Y Yu, ... American journal of cancer research 9 (5), 999, 2019 | 40 | 2019 |
Comprehensive analysis of ECHDC3 as a potential biomarker and therapeutic target for acute myeloid leukemia: Bioinformatic analysis and experimental verification Y Zhao, LT Niu, LJ Hu, M Lv Frontiers in oncology 12, 947492, 2022 | 3 | 2022 |
Effect of MALAT1 in the crosstalk between nucleus and mitochondria on mitochondrial reprogramming in hepatocellular carcinoma cells. Y Zhao, J Cui, J Hu, AR Hoffman Journal of Clinical Oncology 37 (15_suppl), e14711-e14711, 2019 | 3 | 2019 |
MRD-directed and risk-adapted individualized stratified treatment of AML Y Zhao, H Guo, Y Chang Chinese Journal of Cancer Research 35 (5), 451, 2023 | 1 | 2023 |